UTHR UNITED THERAPEUTICS Corp

Nasdaq unither.com


$ 446.19 $ -8.10 (-1.79 %)    

Friday, 31-Oct-2025 15:59:59 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 445.43
$ 451.60
$ 444.95 x 12
$ 469.00 x 7
$ 440.51 - $ 452.53
$ 266.98 - $ 479.50
753,608
na
19.18B
$ 0.56
$ 15.08
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-29-2025 09-30-2025 10-Q
2 07-30-2025 06-30-2025 10-Q
3 04-30-2025 03-31-2025 10-Q
4 02-26-2025 12-31-2024 10-K
5 10-30-2024 09-30-2024 10-Q
6 07-31-2024 06-30-2024 10-Q
7 05-01-2024 03-31-2024 10-Q
8 02-21-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-03-2023 03-31-2023 10-Q
12 02-22-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-04-2022 03-31-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-03-2021 09-30-2021 10-Q
18 08-04-2021 06-30-2021 10-Q
19 05-05-2021 03-31-2021 10-Q
20 02-24-2021 12-31-2020 10-K
21 10-28-2020 09-30-2020 10-Q
22 07-29-2020 06-30-2020 10-Q
23 04-29-2020 03-31-2020 10-Q
24 02-26-2020 12-31-2019 10-K
25 10-30-2019 09-30-2019 10-Q
26 07-31-2019 06-30-2019 10-Q
27 05-01-2019 03-31-2019 10-Q
28 02-27-2019 12-31-2018 10-K
29 10-31-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 05-02-2018 03-31-2018 10-Q
32 02-21-2018 12-31-2017 10-K
33 10-25-2017 09-30-2017 10-Q
34 07-27-2017 06-30-2017 10-Q
35 04-26-2017 03-31-2017 10-Q
36 02-22-2017 12-31-2016 10-K
37 10-27-2016 09-30-2016 10-Q
38 07-28-2016 06-30-2016 10-Q
39 04-28-2016 03-31-2016 10-Q
40 02-25-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-united-therapeutics-raises-price-target-to-525

HC Wainwright & Co. analyst Andrew S. Fein maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price t...

 rbc-capital-maintains-outperform-on-united-therapeutics-raises-price-target-to-587

RBC Capital analyst Lisa Walter maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target fr...

 wells-fargo-maintains-equal-weight-on-united-therapeutics-raises-price-target-to-423

Wells Fargo analyst Benjamin Burnett maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price ta...

 sp-500-tops-6900-ahead-fed-rate-move-gold-reclaims-4000-whats-moving-markets-wednesday

A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelle...

 united-therapeutics-to-present-latest-pulmonary-hypertension-data-at-chest-2025-in-chicago

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced two presentations at the upcoming...

 morgan-stanley-maintains-equal-weight-on-united-therapeutics-raises-price-target-to-435

Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price ta...

 ubs-maintains-buy-on-united-therapeutics-raises-price-target-to-580

UBS analyst Ashwani Verma maintains United Therapeutics (NASDAQ: UTHR) with a Buy and raises the price target from $560 to $...

 this-united-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 rbc-capital-initiates-coverage-on-united-therapeutics-with-outperform-rating-announces-price-target-of-569

RBC Capital analyst Lisa Walter initiates coverage on United Therapeutics (NASDAQ: UTHR) with a Outperform rating and announ...

 united-therapeutics-to-showcase-new-lung-disease-research-at-major-european-medical-conference

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its c...

 cantor-fitzgerald-maintains-overweight-on-united-therapeutics-raises-price-target-to-525

Cantor Fitzgerald analyst Olivia Brayer maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price t...

 wayfair-united-therapeutics-and-ciena-are-among-the-top-10-large-cap-gainers-last-week-sep-1-sep5-are-the-others-in-your-portfolio-corrected

These ten large-cap stocks were top performers last week. Are they a part of your portfolio?

 oppenheimer-maintains-outperform-on-united-therapeutics-raises-price-target-to-575

Oppenheimer analyst Andreas Argyrides maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price tar...

 hc-wainwright--co-maintains-buy-on-united-therapeutics-raises-price-target-to-500

HC Wainwright & Co. analyst Andrew Fein maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price targ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION